How can we empower users to manage their injections and enhance their treatment experience? Haememo achieves this through collaboration with Novo Nordisk, assisting patients in taking their medication effectively. Haememo offers patients a reliable digital companion throughout their treatment and provides that freedom and independence, Haememo supports users from initial treatment to ongoing care, helping them stay informed, prepared, and in control.
A hemophilia diagnosis marks the beginning of a complex and often overwhelming journey. Patients must manage side effects, medication schedules, frequent appointments, and emotional challenges. Maintaining a sense of control can be difficult, especially when care is delivered across different providers and systems.
Challenge
To ensure we built something truly meaningful, we partnered closely with Novo Nordisk to understand what are the crucial needs and pains that patients need to overcome. We needed to understand that giving the patients a sense of control, independence, and safety was crucial for patient saftey and experience.
Approach
Haememo is a digital companion designed to support Hemophilia patients throughout their treatment. It offers habit-building tools and access to helpful information. Whether patients are newly diagnosed or continuing long-term care, Haememo adapts to their needs and helps make each day more manageable.
Solution
Treatment plan
Patients can view and monitor their treatment.
Inventory
Users can add products manually or scan.
Onboarding
Ensure smooth onboarding by informing new users.
Key features
